The largest database of trusted experimental protocols

16 protocols using px459 plasmid

1

CRISPR-Mediated Gene Knockout in HEK293A and B16-OVA Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CRISPR genomic editing technology was used to delete genes in HEK293A and B16-OVA cells. The guide RNA sequences were cloned into the px459 plasmid (Addgene 48319). The constructed plasmids were transfected into HEK293A or B16-OVA using PolyJet. 24 h after transfection, the transfected cells were enriched by 2 μg/ml puromycin selection for 2–3 days and then were sorted into 96-well plates with only one cell in each well by FACS (UCSD; Human Embryonic Stem Cell Core, BDInflux). The clones were screened by western blot analysis with gene-specific antibodies. B16-OVA/LATS1/2 DKO, HEK293A/MST1/2 DKO and MAP4K4/6/7 TKO cells were generated as previously described38 (link),39 (link).
The single-guide RNA (sgRNA) sequences targeting individual genes were as follows:
human HSF-1#1: 5’-CAGCTTCCACGTGTTCGACC-3’;
human PP5#1: 5’-CGCGCTGCGAGACTACGAGA-3’;
human PP5#2: 5’-ACGCGCTGGGAGACGCCACG-3’;
human HSPA1A#2: 5’-AACCGGCATGGCCAAAGCCG-3’;
human HSPA1A#3: 5’-GGTGCTGGACAAGTGTCAAG-3’;
human HSPA1B#2: 5’-CACCGGCATGGCCAAAGCCG-3’;
human HSPA1B#3: 5’-GGTTCTGGACAAGTGTCAAG-3’;
human HSP90AA1#3: 5’-TTCTCTTGCAGGTGAACCTA-3’;
human HSP90AB1#3: 5’-CATTGCTATTTATTCCTCGT-3’;
mouse YAP1#2: 5’-GCCCAAGTCCCACTCGCGAC-3’,
mouse WWTR1#2: 5’-GCAGTGTCCCAGCCGAATCT-3’.
+ Open protocol
+ Expand
2

Generating Mov10 Knockout Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Guide RNAs (Additional file 14) were designed to the mouse Mov10 locus as described in [63 (link)] and cloned into pX459 plasmid (Addgene, Cambridge, MA, USA). Constructs were transfected into WT N2a, serially diluted into 96-well plates, and grown under puromycin (2 μg/mL) selection. Puromycin-resistant colonies were selected and screened for Mov10 expression using western blot analysis and confirmed by sequencing.
+ Open protocol
+ Expand
3

CRISPR-Mediated Knockout of KAP1 and STING/MAVS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Guide RNAs (sgRNAs, see Appendix Table S2) specific to several different exons of KAP1 (exons 1 and 9) were designed using the website: http://crispr.mit.edu/and cloned into the PX459 plasmid (Addgene), which was then transfected into HeLa and HEK293 T cells. After 24 h, the cells were subjected to puromycin selection for 24 h or until control cells had completely died. The bulk population was then used for single‐cell cloning by limiting dilution. Knockout was assessed across a panel of clones by Western blotting using the KAP1 antibody, MAB3662 (Millipore), and validated functionally using KAP1‐KZNF reporter assays. For knockout of STING or MAVS, sgRNAs (listed in Appendix Table S2) were cloned into lentiCRISPRv2 and THP‐1 cells transduced, selected with puromycin and single cell cloned as above.
+ Open protocol
+ Expand
4

Engineered ANKLE1 Constructs and Gene Knockouts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Codons optimized ANKLE1615 (for expression in Escherichia coli) carrying an N‐terminal 6xHis tag cloned in pET100/D‐TOPO vector was purchased from GeneArt (Thermo Fisher Scientific). The ANKLE1669 cDNA cloned in pcDNA3.1+/N‐eGFP vector was purchased from Genescript (clone ID: OHU12449). The ANKLE1615, ANKLE1129‐615, ANKLE11‐420, ANKLE11‐360 and ANKLE11‐128 carrying a N‐terminal GFP tag were generated by PCR and cloned into pcDNA5/FRT/TO vector or pcDNA3.1+ vector. The catalytic‐dead mutant of ANKLE1, ANKLE1Y453A, was generated using a QuikChange Lightning Multi Site‐Directed Mutagenesis kit (Agilent). To generate the sgRNA vectors for gene knockout, pairs of annealed oligonucleotides were cloned into the pX459 plasmid (Addgene 62988) according to the published protocol.[44] The following sequences of sgRNA oligonucleotides were used for gene targeting:
ANKLE1: 5’‐CACCGTCCGCGTGTCGAGATCCTGC‐3’ and 5’‐AAACGCAGGATCTCGACACGCGGAC‐3’
GEN1: 5’‐CACCGCACATCCCCTTGCGTAATCT‐3’ and 5’‐AAACAGATTACGCAAGGGGATGTGC‐3’[45]MUS81: 5’‐CACCGTCTGAAATACGAAGCGCGTG‐3’ and 5’‐AAACCACGCGCTTCGTATTTCAGAC‐3’[45]TREX1: 5’‐CACCGGAGCCCCCCCACCTCTC‐3’ and 5’‐AAACGAGAGGTGGGGGGGCTCC‐3’[11]STING: 5’‐CACCGCATATTACATCGGATATCTG‐3’ and 5’‐AAACCAGATATCCGATGTAATATGC‐3’
+ Open protocol
+ Expand
5

CRISPR-Mediated Gene Knockout in HEK293A and B16-OVA Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CRISPR genomic editing technology was used to delete genes in HEK293A and B16-OVA cells. The guide RNA sequences were cloned into the px459 plasmid (Addgene 48319). The constructed plasmids were transfected into HEK293A or B16-OVA using PolyJet. 24 h after transfection, the transfected cells were enriched by 2 μg/ml puromycin selection for 2–3 days and then were sorted into 96-well plates with only one cell in each well by FACS (UCSD; Human Embryonic Stem Cell Core, BDInflux). The clones were screened by western blot analysis with gene-specific antibodies. B16-OVA/LATS1/2 DKO, HEK293A/MST1/2 DKO and MAP4K4/6/7 TKO cells were generated as previously described38 (link),39 (link).
The single-guide RNA (sgRNA) sequences targeting individual genes were as follows:
human HSF-1#1: 5’-CAGCTTCCACGTGTTCGACC-3’;
human PP5#1: 5’-CGCGCTGCGAGACTACGAGA-3’;
human PP5#2: 5’-ACGCGCTGGGAGACGCCACG-3’;
human HSPA1A#2: 5’-AACCGGCATGGCCAAAGCCG-3’;
human HSPA1A#3: 5’-GGTGCTGGACAAGTGTCAAG-3’;
human HSPA1B#2: 5’-CACCGGCATGGCCAAAGCCG-3’;
human HSPA1B#3: 5’-GGTTCTGGACAAGTGTCAAG-3’;
human HSP90AA1#3: 5’-TTCTCTTGCAGGTGAACCTA-3’;
human HSP90AB1#3: 5’-CATTGCTATTTATTCCTCGT-3’;
mouse YAP1#2: 5’-GCCCAAGTCCCACTCGCGAC-3’,
mouse WWTR1#2: 5’-GCAGTGTCCCAGCCGAATCT-3’.
+ Open protocol
+ Expand
6

Construction of STARR Reporter Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The AR expression construct was modified from the pGFP-AR plasmid (20 (link)) by replacing a NheI-BspTI fragment containing EGFP and 510 bp of human AR and replacing it with a PCR-amplified fragment with primer-introduced ATG, NheI and BspTI sites. Individual STARR reporter constructs were generated by digesting the human STARR-seq vector (21 (link)) with SalI and AgeI and subsequent insertion of fragments of interest by In-Fusion HD cloning (TaKaRa). Fragments of interest: positive control region (near IP6K3 gene, hg19: chr6:33 698 504–33 698 853), AQP3 enhancer (hg19: chr9:33 437 258–33 437 811) and the AQP3 enhancer with AR binding site mutations (AQP3-Deleted and AQP3-AGA → TGT) were ordered as a gBlock (IDT) or GeneStrand (Eurofins) (see Supplementary Table S1 for the sequence of regions).
Oligos (Supplementary Table S2) encoding guide RNAs to delete the region downstream of the AQP3 gene were designed using the CRISPR Design tool (22 (link)), annealed and cloned into BbsI digested PX459 plasmid (Addgene #62988, (23 (link))) to generate plasmids PX459-AQP3_214 and PX459-AQP3_216.
+ Open protocol
+ Expand
7

Cloning CRISPR sgRNA into PX459 for 3T3 transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The candidate sgRNA sequences were annealed and cloned into a PX459 plasmid (Addgene plasmid, 48139), after restriction digestion with Esp3I (Thermo Fisher Scientific, FD0454). PX459 vectors with candidate sgRNAs were then seeded in 6-well plates and transfected into NIH-3T3 cells (at 60% confluence) using Lipofectamine™ 3000 (Invitrogen, L3000075) according to the manufacturer's protocol. The transfected cells were selected using Puromycine (2.5 µg/mL) prior to use for subsequent studies.
+ Open protocol
+ Expand
8

CRISPR-Mediated Knockout of p190A Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
The guide oligos targeting the p190A gene were subcloned into the pX459 plasmid (Addgene, USA). After 24 h, cells were cultured in 1 µg/ml puromycin for 3 days. Surviving cells were seeded in a 96-well plate by limited dilution to isolate the monoclonal cell lines. KO cell clones were detected by WB and validated by Sanger sequencing. The sequences of sgRNA and primers for amplification of the sgRNA-targeted sequence of the p190A gene are listed in Supplementary Tables 3 and 4.
+ Open protocol
+ Expand
9

FAM83A Gene Knockout Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
FAM83A-sgRNA/Cas9 plasmid vector was constructed using pX459 plasmid, which was purchased from Addgene (#48139). Two candidate sequences to target Mus musculus FAM83A were designed on the Zhangfeng Lab guide-design website (https://zlab.bio/guide-design-resources).
FAM83A-sgRNA1/Cas9 F: CACCGGGCAAGATCCGGAAACGTC
FAM83A-sgRNA1/Cas9 R: AAACGACGTTTCCGGATCTTGCCC
FAM83A-sgRNA2/Cas9 F: CACCGGTAGACTTCCTGTCCTCAG
FAM83A-sgRNA2/Cas9 R: AAACCTGAGGACAGGAAGTCTACC
The primer sequences of genotyping for the FAM83A-KO.
FAM83A-sgRNA/Cas9-g F: CTACGTCTGGAAGAGCTCCG
FAM83A-sgRNA/Cas9-g R: TCAGCCAAAGTCCAGGTGTG
+ Open protocol
+ Expand
10

CRISPR-Cas9 Mediated UCHL1 Knockout in HEK293E and SH-SY5Y Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CRISPR-Cas9 system was used for the generation of UCHL1 KO cells19 (link). To generate UCHL1 KO HEK293E cells, the guide RNA sequence (GTGGCGCTTCGTGGACGTGC) was inserted into the PX459 plasmid (62988, Addgene). The vector was transfected into HEK293E cells. 2 days after transfection, the transfected cells were selected with puromycin (5 μg/ml) for 3 days. Then, single colonies were transferred onto 96-well plates with one colony in each well. Immunoblot analysis with anti-UCHL1 antibody (13179S, Cell signaling) was performed to screen UCHL1 KO clones. UCHL1 KO SH-SY5Y cells were generated in the previous paper19 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!